Clovis Oncology, Inc. (NASDAQ:CLVS) Ratings Summary on April 13, 2018

The biopharmaceutical company reported ($1.83) earnings per share for the quarter, missing the consensus estimate of ($1.65) by $0.18. The company has market cap of $2.36 billion. The stock decreased 1.30% or $0.8 during the last trading session, reaching $60.64. Gamco Incorporated Et Al has 7,920 shares for 0% of their portfolio. Delta Air Lines, Inc. It is down 43.98% since April 15, 2017 and is downtrending. It has outperformed by 30.52% the S&P500. On Thursday, November 2 Morgan Stanley maintained Clovis Oncology, Inc. Charter Trust Company sold 5,981 shares as Procter & Gamble Co (PG)'s stock declined 15.56%. Sivik Global Health Lc reported 35,000 shs.

Analysts await Clovis Oncology, Inc. Insiders have sold a total of 19,500 shares of company stock worth $1,156,455 over the last ninety days. About 686,060 shares traded.

Clovis Oncology (NASDAQ:CLVS) last announced its quarterly earnings results on Wednesday, February 22nd. CLVS underperformed the S&P500 by 32.98%. 894 shares valued at $50,511 were sold by Smith Joanne D on Monday, December 18. 738,870 shares of the company were exchanged, compared to its average volume of 1,168,992. (NYSE:DAL) on Friday, February 2. About 337,567 shares traded.

During 2017 Q4 the big money sentiment decreased to 1.05. Its up 0.07, from 0.82 in 2017Q3. 40 funds opened positions while 74 raised stakes. Barclays Plc holds 162,124 shs or 0.01% of its capital. Tiaa Cref Inv Mgmt Ltd Com holds 0.01% or 310,496 shs. (NASDAQ:CLVS). Balyasny Asset Management Limited Liability Com has 313,245 shs for 0.07% of their capital. The Assetmark Inc holds 29,821 shares with $1.60M value, up from 6,283 last quarter. Pictet Asset Mngmt reported 0.07% stake.

Eurobank Ergasias S.A. provides retail, corporate and private banking, asset management, treasury, capital markets, and other services. Fin Counselors holds 0.1% or 57,219 shares. Macquarie Group Limited has 0.06% invested in The Procter & Gamble Company (NYSE:PG) for 396,481 shares. (NYSE:DAL). Moreover, Banced has 0.66% invested in Delta Air Lines, Inc. Steelhead Prtn Limited Liability Company reported 0.07% stake. 501,791 are held by National Bank Of Montreal Can. JPMorgan Chase reiterated a "buy" rating on shares of Clovis Oncology in a research report on Thursday, January 11th. Therefore 67% are positive. (NASDAQ:CLVS) with "Buy" rating. The company was initiated on Friday, March 23 by Oppenheimer. The firm earned "Hold" rating on Wednesday, December 21 by WallachBeth Capital. (NYSE:DAL) on Thursday, March 16 to "Outperform" rating. The firm has "Overweight" rating given on Wednesday, May 17 by JP Morgan. The company was maintained on Thursday, July 13 by Stifel Nicolaus. Stifel Nicolaus maintained Clovis Oncology, Inc. The firm has "Buy" rating by Leerink Swann given on Monday, February 5. On Tuesday, November 17 the stock rating was downgraded by Goldman Sachs to "Neutral".

Md Sass Investors Services Inc, which manages about $1.91 billion and $1.12B US Long portfolio, upped its stake in Koninklijke Philips N V (NYSE:PHG) by 556,440 shares to 1.00M shares, valued at $37.97M in 2017Q4, according to the filing.

Investors sentiment increased to 1.34 in 2017 Q4. Its down 0.39, from 1.44 in 2017Q3. The ratio worsened, as 109 investment professionals increased and started new stock positions, while 104 reduced and sold their stakes in Clovis Oncology Inc. Tarbox Family Office Inc reported 100 shares. Camber Capital Management Llc acquired 400,000 shares as Clovis Oncology Inc (CLVS)'s stock declined 18.56%. Clovis Oncology has a 52 week low of $45.42 and a 52 week high of $99.45. (NASDAQ:CLVS) for 78,944 shares. Raymond James Fincl Advsr has invested 0.01% in Clovis Oncology, Inc. (NASDAQ:CLVS). Metropolitan Life Ins stated it has 0.01% of its portfolio in Clovis Oncology, Inc. (NASDAQ:CLVS). 153,735 are owned by Clough Cap L P. California-based Franklin Resources Inc has invested 0.09% in Clovis Oncology, Inc. (NASDAQ:CLVS) PTs and latest ratings. Frontier Cap Ltd Co reported 43,276 shares. Texas-based Qcm Cayman has invested 1.04% in Clovis Oncology, Inc. (NASDAQ:CLVS). Bancorp Of New York Mellon stated it has 251,802 shares. (NASDAQ:CLVS). State Board Of Administration Of Florida Retirement System invested in 0% or 25,073 shares. It also reduced its holding in Micron Technology Inc (NASDAQ:MU) by 663,841 shares in the quarter, leaving it with 775,667 shares, and cut its stake in Alcoa Corp.

Since October 16, 2017, it had 0 insider purchases, and 6 insider sales for $1.37 million activity. Clovis Oncology had 64 analyst reports since September 10, 2015 according to SRatingsIntel. SPICKSCHEN THORLEF sold $276,615 worth of stock.

Among 20 analysts covering Clovis Oncology (NASDAQ:CLVS), 16 have Buy rating, 0 Sell and 4 Hold. Therefore 48% are positive. After having $1.01 EPS previously, SCANA Corporation's analysts see 19.80% EPS growth. As per Tuesday, January 23, the company rating was maintained by Hovde Group. On Thursday, February 22 Evercore upgraded Clovis Oncology, Inc. In Friday, April 6 report SunTrust maintained the stock with "Buy" rating. The stock rating was maintained by SunTrust with "Buy" on Friday, April 6.